Answer
Yes. The selected eye-drop product is licensed to slow progressing myopia in eligible children and requires specialist initiation and follow-up.
Sources for this answer
- Ryjunea 0.1 mg/ml eye drops, solution — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.